Solitary intramedullary spinal cord metastasis from primary sinonasal mucosal melanoma: a case report
Frontiers in Oncology · 20.11.2026 · 16
DOI: 10.3389/fonc.2026.1946908 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.11.2026. Verfasst von Fang He und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sinonasal mucosal melanoma is a rare, highly aggressive malignancy, and delayed solitary intramedullary spinal cord metastasis from sinonasal mucosal melanoma is exceptionally rare uncommon. This case report describes a 77-year-old male patient with Sinonasal mucosal melanoma who, during a 14-month follow-up period, developed a secondary, isolated intramedullary metastasis at the T11 level, exhibiting characteristic features of intramedullary origin and trans-leptomeningeal infiltration. In this patient, complete paraplegia developed shortly after surgery and progressed rapidly to death. This case illustrates that delayed solitary ISCM may be associated with rapid neurological decline. Clinicians should remain alert to new neurological symptoms and consider timely central nervous system (CNS) imaging when clinically indicated.
Zitieren
APA
He, F., Jie, P., Dai, X., Liu, Y., & Luo, W. (2026). Solitary intramedullary spinal cord metastasis from primary sinonasal mucosal melanoma: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1946908
Vancouver
He F, Jie P, Dai X, Liu Y, Luo W. Solitary intramedullary spinal cord metastasis from primary sinonasal mucosal melanoma: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1946908
BibTeX
@article{He2026,
author = {He, Fang and Jie, Pingping and Dai, Xiong and Liu, Yong and Luo, Weidan},
title = {Solitary intramedullary spinal cord metastasis from primary sinonasal mucosal melanoma: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1946908}
}
EUVIMED